Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05284643 · ClinicalTrials.gov registry record · NA

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

A NA study of Recurrent Glioblastoma, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
96
Enrollment target
1
Study location

NCT05284643 is a NA study of Recurrent Glioblastoma that is actively recruiting participants, run by University of Miami. The registered enrollment target is 96 participants, above the 67-participant average among 62 other Recurrent Glioblastoma trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05284643, a NA study of Recurrent Glioblastoma, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
96 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to find hidden cancer with an experimental magnetic resonance imaging (MRI) scan called spectroscopic magnetic resonance imaging (sMRI). That spectroscopic MRI scan will be used to increase the area of the brain receiving radiation and then the dose of radiation in attempt to kill more of the cancer. Proton radiotherapy and bevacizumab (Avastin) are used to minimize the possible side effects of this approach.

Conditions Studied

Recurrent Glioblastoma

Interventions

  • DRUG Bevacizumab
  • RADIATION Intensity Modulated Proton Therapy (IMPT)

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2022-09-30
Est. Completion 2029-09-30
Phase NA

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05284643

The ClinicalTrials.gov registry entry for NCT05284643 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 67-participant average among 62 other Recurrent Glioblastoma trials with a reported enrollment target (43% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Recurrent Glioblastoma appearing as the primary indexed condition, and to 2 interventions - of which Bevacizumab is the first listed.

NCT05284643 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05284643 about?

NCT05284643 is a clinical study titled "Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma". The purpose of this research is to find hidden cancer with an experimental magnetic resonance imaging (MRI) scan called spectroscopic magnetic resonance imaging (sMRI). That spectroscopic MRI scan will be used to increase the area of the brain receiving radiation and then the dose of radiation in at...

What is the current status of trial NCT05284643?

This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2022-09-30. Estimated completion is 2029-09-30.

What conditions does trial NCT05284643 study?

This clinical trial studies the following conditions: Recurrent Glioblastoma.

What interventions are being tested in trial NCT05284643?

The interventions under investigation include: Bevacizumab (DRUG), Intensity Modulated Proton Therapy (IMPT) (RADIATION).

Who is sponsoring clinical trial NCT05284643?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05284643 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Recurrent Glioblastoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Recurrent Glioblastoma

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.